Connection
Robert Freedman to Treatment Outcome
This is a "connection" page, showing publications Robert Freedman has written about Treatment Outcome.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.163 |
|
|
|
-
Freedman R. Ketamine and ECT in Depression - Risks and Rewards. N Engl J Med. 2023 06 22; 388(25):2389-2390.
Score: 0.066
-
Olincy A, Blakeley-Smith A, Johnson L, Kem WR, Freedman R. Brief Report: Initial Trial of Alpha7-Nicotinic Receptor Stimulation in Two Adult Patients with Autism Spectrum Disorder. J Autism Dev Disord. 2016 Dec; 46(12):3812-3817.
Score: 0.042
-
Freedman R, Carpenter WT, Davis JM, Goldman HH, Tamminga CA, Thomas M. The costs of drugs for schizophrenia. Am J Psychiatry. 2006 Dec; 163(12):2029-31.
Score: 0.021
-
Gabbard GO, Freedman R. Psychotherapy in the Journal: what's missing? Am J Psychiatry. 2006 Feb; 163(2):182-4.
Score: 0.020
-
Kantrowitz JT, Javitt DC, Freedman R, Sehatpour P, Kegeles LS, Carlson M, Sobeih T, Wall MM, Choo TH, Vail B, Grinband J, Lieberman JA. Double blind, two dose, randomized, placebo-controlled, cross-over clinical trial of the positive allosteric modulator at the alpha7 nicotinic cholinergic receptor AVL-3288 in schizophrenia patients. Neuropsychopharmacology. 2020 07; 45(8):1339-1345.
Score: 0.013
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|